首页> 外文期刊>Experimental and therapeutic medicine >Effects of glucocorticoids combined with probiotics in treating Crohn's disease on inflammatory factors and intestinal microflora
【24h】

Effects of glucocorticoids combined with probiotics in treating Crohn's disease on inflammatory factors and intestinal microflora

机译:糖皮质激素联合益生菌治疗克罗恩疾病对炎症因子和肠道微生物的影响

获取原文
获取原文并翻译 | 示例
           

摘要

This study investigated the effect of glucocorticoids combined with probiotics on inflammatory factors and intestinal microflora in the treatment of Crohn's disease. Eighty-three patients with Crohn's disease were selected from March 2015 to December 2017 in PLA Army General Hospital (Beijing, China). A total of 83 patients were randomly divided into the control group and treatment group. Patients in the control group were treated with routine treatment of oral sulfasalazine. Besides oral sulfasalazine, patients in the treatment group were treated with probiotics combined with glucocorticoids. At the same time, a total of 40 healthy individuals were selected to serve as the healthy group (received no treatment). Clinical efficacy, changes of inflammatory factors, incidence of infection and changes of intestinal flora were compared between the different groups. After treatment, the levels of inflammatory factors in both groups significantly decreased, and the reduction in the treatment group significantly increased than that in the control group (P0.05). The levels of inflammatory cytokines in the treatment group reached the levels of that in the healthy individuals after treatment. After treatment, the levels of yeast, enterococci and peptococcus of the two groups of patients were significantly decreased, while the level of lactobacillus was significantly increased, and the changes were more significant in the treatment group than those in the control group. After treatment, the number of intestinal flora in the treatment group reached that of the healthy individuals. Treatment efficiency of the treatment group was significantly higher than that of the control group, and the infection rate of the control group was significantly higher than that of the treatment group (P0.05). The use of probiotics combined with glucocorticoid in the treatment of Crohn's disease can improve clinical curative effect, reduce the secretion of inflammatory factors and improve the level of intestinal flora, so as to achieve better outcomes compared with conventional method.
机译:本研究调查了糖皮质激素与益生菌联合对炎症因子和肠道微生物的影响治疗克罗恩病的兴奋剂。克罗恩病患者于2015年3月至2017年12月在中国陆军综合医院(中国北京)。共有83名患者随机分为对照组和治疗组。对照组患者用常规治疗口服磺基碱治疗。除了口服磺基碱外,治疗组中的患者均用益生菌与糖皮质激素合并处理。同时,共选出40个健康个体以作为健康组(未接受治疗)。在不同的组之间比较了不同组的临床疗效,炎症因子的变化,感染发生和肠道菌群的变化。治疗后,两组炎症因子的水平显着降低,治疗组的减少显着增加到对照组(P <0.05)。治疗组炎性细胞因子的水平达到治疗后健康个体的水平。治疗后,两组患者的酵母,肠球菌和脑痛的水平显着下降,而乳酸杆菌水平显着增加,治疗组中的变化比对照组更重要。治疗后,治疗组中肠道菌群的数量达到了健康个体。治疗组的治疗效率明显高于对照组的效率,对照组的感染率明显高于治疗组(P <0.05)。益生菌的使用结合糖皮质激素在治疗克罗恩病中可以提高临床疗效,减少炎症因素的分泌,提高肠道菌群水平,从而达到更好的结果与常规方法相比。

著录项

  • 来源
  • 作者单位

    PLA Army Gen Hosp Dept Gastroenterol 5 Nanmencang Beijing 100700 Peoples R China;

    PLA Army Gen Hosp Dept Gastroenterol 5 Nanmencang Beijing 100700 Peoples R China;

    PLA Army Gen Hosp Dept Gastroenterol 5 Nanmencang Beijing 100700 Peoples R China;

    PLA Army Gen Hosp Dept Gastroenterol 5 Nanmencang Beijing 100700 Peoples R China;

    PLA Army Gen Hosp Dept Gastroenterol 5 Nanmencang Beijing 100700 Peoples R China;

    PLA Army Gen Hosp Dept Gastroenterol 5 Nanmencang Beijing 100700 Peoples R China;

    PLA Army Gen Hosp Dept Gastroenterol 5 Nanmencang Beijing 100700 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 治疗学;
  • 关键词

    Crohn's disease; probiotics; glucocorticoid; intestinal flora;

    机译:克罗恩病;益生菌;糖皮质激素;肠道菌群;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号